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Malnutrition in hemodialysis diabetic patients:
Evaluation and prognostic influence
NOE¨L J.M. CANO, HUBERT ROTH, MICHEL APARICIO, RAYMOND AZAR, BERNARD CANAUD,
PHILIPPE CHAUVEAU, CHRISTIAN COMBE, DENIS FOUQUE, MAURICE LAVILLE, XAVIER M.
LEVERVE, and the French Study Group for Nutrition in Dialysis (FSG-ND)1
Malnutrition in hemodialysis diabetic patients: Evaluation and and vascular disease conditions [4]. The nutritional status
prognostic influence. of diabetic patients on dialysis may also influence the
Background. This work aimed to evaluate the role of malnu- survival of these patients. Indeed, diabetic patients withtrition in the increased mortality rate of hemodialysis diabetic
chronic renal failure are considered to be at increasedpatients from a French cooperative series.
risk of malnutrition [5, 6]. However, only few data areMethods. Body mass index (BMI), serum albumin, prealbu-
min, cholesterol, and pre-dialysis creatinine, normalized pro- available concerning the nutritional status of diabetic
tein catabolic rate and lean body mass (LBM) were measured patients on dialysis [7–10]. As malnutrition now is consid-
in 734 diabetic and 6389 non-diabetic patients (aged 63.4 
ered as a major cause of morbidity and mortality in12.2 and 62.0  15.9 years; 1.01 male to 1.40 female ratio).
hemodialysis patients [7, 11–15], the aims of the presentThe outcome of 1610 of these patients, including 170 diabetics,
was assessed during a 30-month follow-up. work were twofold: (1) to assess the nutritional status
Results. Diabetic as compared to non-diabetic patients of diabetic patients from a large French National cross-
showed a significant (P  104) increased BMI (25.9  5.2 vs. sectional survey [10]; and (2) to study the influence of23.1  4.3) and cholesterol (5.5  1.6 vs. 5.3  1.5 mmol/L),
nutritional status on patient outcome in a prospectiveand decreased albumin (37.8 5.4 vs. 38.9 5.3 g/L), prealbu-
longitudinal survey of a subset of this population [1].min (317  91 vs. 340  94 mg/L), creatinine (711  184 vs.
816 217 mol/L) and LBM (76 18 vs. 87 21%). Normal-
ized protein catabolic rate was similar in the two groups (1.11
0.31 vs. 1.13  0.32 g/kg/L). One and two-year survival was METHODS
83.7 2.9% and 65.5 3.8% in diabetic patients versus 90.3
Data collection0.8% and 79.9  1.1% in non-diabetics (relative risk 1.26, P 
0.01). Independent predictors of survival were age, albumin Cross-sectional nutritional evaluation. Nutritional data
and prealbumin in non-diabetics and only age in diabetics. from 7123 patients representing one third of French he-
Conclusion. Diabetic patients compared to non-diabetics
modialysis patients were obtained from 106 hemodialysiswere characterized by an increased incidence of protein malnu-
centers, which agreed to participate in this survey andtrition and decreased survival. However, the higher death risk
associated with diabetes was not related to malnutrition. provided a questionnaire for each patient from January
to April 1996. Complete data collection has been re-
ported elsewhere [10]. The present article concerns data
As recently confirmed by European, Japanese and obtained in the 734 diabetic patients whose data were
U.S. reports, diabetes mellitus remains associated with compared with those of the 6689 non-diabetic patients
the highest mortality rates in hemodialysis patients when (Table 1). The questionnaire included items related to
compared with the other causes of end-stage renal dis- dialysis schedule and nutritional status. The date of first
ease [1–3]. The poor prognosis of diabetic hemodialysis dialysis session and type of dialysis facility (“in-hospital”
patients is usually attributed to their co-morbid cardiac dialysis center, “self-dialysis” center, and home dialysis)
were recorded. Standard dialysis treatment consisted
mostly of three weekly sessions using bicarbonate buffer1 A complete list of the dialysis centers involved in this study is provided
in the Acknowledgments. without re-use of dialyzers. Weekly dialysis duration was
12 hours in about 80% of patients. Dialysis dose deliveryKey words: diet and dialysis, protein status, malnutrition, diabetes mel-
litus, death and diabetes, mortality and hemodialysis, dialysis in France. was estimated from the urea Kt/V [16]. Nutritional data
were recorded on a mid-week dialysis session. Body mass
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index (BMI) was obtained from height and post-dialysisand in revised form February 25, 2002
Accepted for publication March 5, 2002 body mass, while ideal body mass was calculated using
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Table 2. Nutritional parameters in diabetic and non-diabeticTable 1. General and dialysis data in diabetic and non-diabetic
patients in the 1996 series patients in the 1996 series
Diabetic Non-diabeticDiabetic Non-diabetic
patients patients patients patients
(N  734) (N  6389)(N  734) (N  6389)
Age years 63.412.2 62.015.9 Body weight % ideal BW 11825a 10422
Body mass index 25.95.2a 23.14.3Sex ratio M/F 1.01a 1.40
Vintage months 30.827.8a 66.067.8 Serum albumin g/L 37.85.4a 38.95.3
Serum prealbumin mg/L 31791a 34094Dialysis facility %
Hospital dialysis 97a 82 Serum cholesterol mmol/L 5.51.6a 5.31.5
Protein catabolic rate g/kg/day 1.110.31 1.130.32Self-dialysis & home dialysis 3a 18
Weekly dialysis time 12.42.7 12.42.5 Serum creatinine lmol/L 711184a 816217
Lean body mass observed/expected 0.760.18a 0.870.21Kt/V 1.300.34a 1.360.36
Plasma bicarbonate mmol/L 22.83.3 22.83.3 The numbers of patients for each diagnosis are given in parentheses. Values
are given as meansSD.Values are given as meansSD.
a Significant difference between the 2 groupsa Significant differences between the 2 groups
survival in diabetic and non-diabetic patients as well as(nPCR) was calculated from urea generation rate [17]
the influence of serum albumin and prealbumin quartilesand was assumed to reflect daily protein intake. Lean
on the survival of diabetic and non-diabetic patients.body mass (LBM) was estimated from the creatinine
Statview 5 software (SAS Institute Inc., Cary, NC,generation [18] and was expressed as the observed/ex-
USA) was used for statistical analysis.pected LBM ratio (LBM obs/exp). Pre-dialysis plasma
bicarbonate, albumin, prealbumin, cholesterol, and pre-
and post-dialysis urea and creatinine concentrations RESULTS
were determined using conventional autoanalyzers.
Cross-sectional nutritional evaluationLongitudinal survey. Twenty of the 106 dialysis cen-
Among the 7123 patients studied in 1996, 734 pre-ters involved in the 1996 cross-sectional survey agreed
sented with diabetes mellitus. General and dialysis datato participate in a prospective study of their patients [1].
of diabetic and non-diabetic population are given in Ta-Thus, data concerning the outcome of 1610 patients were
ble 1. Age, weekly dialysis time, and plasma bicarbonaterecorded in July 1998. Among them, 170 were diabetic.
were similar in the two groups. The sex ratio differedPatient outcome was defined as still on dialysis, lost of
between the groups, however, as women representedfollow-up, or not on dialysis (change of treatment, trans-
50% of diabetic patients and 41% of non-diabetic pa-plantation or death). Causes of death were classified in
tients (P 103). Time spent on dialysis was significantlyfive categories: cancer, infection, cardiac failure, vascular
shorter for diabetic patients (31 vs. 66 months). More-disease and other. Because of the limited number of
over, the proportion of patients dialyzed in hospital cen-patients with type 1 diabetes (11% of diabetics), data
ters was higher in diabetic than in non-diabetic patientsfrom patients with type 1 and type 2 diabetes were
while self-dialysis and home dialysis were less frequentgrouped for statistical analysis.
in diabetic patients (P  103). Although dialysis dura-
Statistical analysis tion was similar in the two groups, Kt/V was significantly
lower in diabetic patients. Considering the recently rec-Results are given as mean  SD. The comparison
ommended KtV values [19], 40% of diabetic patientsof data obtained in diabetic and non-diabetic group of
and 32% of non-diabetics presented with Kt/V valuespatients was made using the Student t test or analysis of
less than 1.2 (P  104). Nutritional parameters in dia-variance (ANOVA) with the PLSD Fisher test. Statisti-
betic and non-diabetic patients are given in Table 2. Ascal significance was set at P  0.05. Nutritional data
obtained in the 1996 cross-sectional study were also pre- compared with non-diabetic patients, diabetic patients
showed increased values (P 104) of body weight, bodysented as histograms of distribution frequency in diabetic
and non-diabetic patients. Categorical variables were mass index, and serum cholesterol, and decreased values
(P 104) of albumin, prealbumin, creatinine and LBMcompared using 2 tests. For technical survival analysis,
data from patients who were transplanted, lost of follow- obs/exp. These differences persisted after an adjustment
for gender. Similar differences in nutritional data fromup or treated by another method were censored. In dia-
betic and non-diabetic groups of patients, parameters diabetic and non-diabetic patients were observed when
only patients with Kt/V values more than 1.2 were con-having a significant impact on survival after univariate
Cox analysis were tested in a multivariate Cox propor- sidered: BMI was 25.9  5.2 in diabetics versus 23.0 
4.4 in non-diabetics (P  104); albumin 37.8  5.4 g/Ltional hazard model. Kaplan-Meier graphs and Log rank
tests were performed in order to study overall cumulated versus 38.9  5.3 g/L (P  104); prealbumin 317 
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Fig. 1. Histograms of nutritional-parameter
distribution in diabetic (N  734) and non-
diabetic patients (N  6389).
91 mg/L versus 340  94 mg/L (P  104); predialysis parameters except for BMI. BMI was less than 20 in
10.8% of diabetics and 22.5% of non-diabetics, whilecreatinine 711  185 mol/L versus 816  217 mol/L
(P  104); and LBM obs/exp 0.79  0.17 versus 0.89  obesity, defined by BMI as 30, was found in 12.9% of
diabetics and 4.8% of non-diabetics (P  103). Con-0.20 (P  104). Normalized catabolic rate was similar
in diabetic and non-diabetic patients. Figure 1 shows the versely, indicators of protein malnutrition were more
severely altered in diabetics than in non-diabetics. Albu-distribution of nutritional parameter values in diabetic
and non-diabetic patients. Diabetic patients were charac- min was 35 g/L in respectively 33.3% and 22.5% (P 
103), prealbumin 300 mg/L in 46.4% and 35.5% (P terized by a shift toward the lowest values of nutritional
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Table 3. Clinical and laboratory data collected at the beginning of the longitudinal survey in patients who died before
the end of follow-up or were still on dialysis
Diabetic patients (N  161) Non-diabetic patients (N  1301)
Deceased Still on dialysis Deceased Still on dialysis
N 69b 83b 324 851
Age years 68.410.7 61.210.5a 69.911.4 58.216.0a
Vintage months 38.029.7b 30.530.0b 64.163.0 74.471.3a
Weekly hemodialysis duration hours 12.11.4 12.41.5 11.81.7 12.31.8a
Bicarbonate mmol/L 23.33.3 23.73.8 23.93.7 23.13.6a
Creatinine before dialysis lmol/L 713180 703195b 723191 851229a
Albumin g/L 39.04.6b 38.25.6b 36.65.5 40.14.7a
Prealbumin mg/L 30983 30881b 29988 34085a
Hemoglobin g% 10.11.3 10.01.5b 10.31.5 10.41.5
Kt/V 1.280.36 1.270.32b 1.320.28 1.370.36
NPCR g/kg/day 1.050.31 1.000.23 1.010.29 1.120.30a
BMI kg/m2 25.24.6b 26.14.9b 22.64.4 22.94.4
LBM obs/exp 0.740.18 0.750.19b 0.780.25 0.890.25a
a Significant difference with deceased patients
b Significant difference with non-diabetic patients
Table 5. Causes of death in diabetic and non-diabetic patientsTable 4. Clinical and laboratory data in diabetic and non-diabetic
grafted patients at the time of inclusion
Diabetic Non-diabetic
patients patientsDiabetic Non-diabetic
patients patients
Cardiac failure % 32.8 31.5(N  9) (N  126)
Vascular disease % 28.4 20.1
Infectious disease % 14.9 14.2Age years 43.114.0 40.814.1
Vintage months 44.648.4 42.145.9 Malignant disease % 9.0 10.7
Other causes % 14.9 23.6Weekly HD duration hours 12.81.9 12.41.8
Creatinine before dialysis lmol/L 882219 913208
Albumin g/L 39.21.4 42.85.4
Prealbumin mg/L 37028 392101
Hb g% 10.21.5 10.41.2
Kt/V 1.360.27 1.330.36 cant lower values of weekly dialysis duration, pre-dialysis
nPCR g/kg/day 1.390.25 1.190.31
creatinine, albumin, prealbumin, nPCR and LBM obs/BMI kg/m2 23.85.1 22.34.1
LBM obs/exp 0.910.19 0.930.19 exp. At the opposite, in diabetic patients, nutritional
parameters were similar whatever the outcome (TableValues are given as meansSD.
3). As shown in Table 4, diabetic and non-diabetic trans-
planted patients appeared to be similar with respect to
age, dialysis data and nutritional parameters. Table 5103), predialysis creatinine 700 mol/L in 50.6% and
gives the causes of death in the two groups. Although30.5% (P  103), and LBM obs/ex  0.80 in 60.6% and
death rates were increased during diabetes, the distribu-39.3% (P  103).
tion of causes of death was similar in diabetic and in
non-diabetic patients.Longitudinal survey
Figure 2 shows Kaplan-Meier plot of survival in dia-Among the 1610 patients entering the longitudinal
betic and non-diabetic patients. Overall survival wassurvey, 90 were lost to follow-up and 58 changed of
83.7  2.9% after one year and 65.5  3.8% after twotreatment modality or moved to another dialysis center.
years in diabetic patients and 90.3 0.8% after one yearNine diabetics and 126 non-diabetics were transplanted
and 79.9  1.1% after two years in non-diabetic patients(5.6 vs. 9.7%, NS). As shown in Table 3, diabetes mellitus
(relative risk 1.26, 95% confidence interval 1.06 to 1.49,was responsible for a significant increase of death during
P 102). In non-diabetic patients, univariate Cox analy-the follow-up (42.8 vs. 25.0% in non-diabetic patients).
sis showed that survival was significantly influenced byAs observed in the 1996’s cross-sectional study, among
age, albumin, prealbumin, pre-dialysis creatinine, nPCR,patients participating to the follow-up study, hemodia-
LBM obs/exp (P  104), weekly dialysis time (P lyzed diabetic patients as compared with non-diabetics
103), and body weight (% ideal BW, P  102). BMI,exhibited lower vintage, higher BMI and decreased val-
plasma cholesterol, hemoglobin, duration on dialysis andues of protein nutritional markers. In diabetics as in non-
Kt/V did not influence survival. Multivariate Cox analy-diabetics, deceased patients were older than patients still
sis showed that, among the parameters significantly in-on dialysis. Among non-diabetics, patients who died be-
fore the end of follow-up were characterized by signifi- fluencing survival after univariate analysis, only age (P
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of diabetics was an increase in body weight and BMI
together with a deterioration of protein markers of nutri-
tion. When considering body weight as expressed as per-
centage of ideal body weight and body mass index, it
cannot be concluded that diabetic patients are under-
nourished since they exhibited significantly higher values
than non-diabetic patients. However, when considering
the significantly lower values of albumin, prealbumin
and predialysis creatinine, the protein status appeared
to be depleted in diabetics. This was further confirmed
by the calculation of the lean body mass, which showed
a reduction by 11% as compared to non-diabetic patients
and by 24% as compared to ideal values for same age
and sex. Among the different etiologies of renal disease
in the whole 1996 series, diabetic patients were character-Fig. 2. Kaplan-Meier plot of survival in diabetic (; N  170) and
non-diabetic patients (; N  1357). Log rank (Mantel-Cox) test, ized by the most severe protein depletion (data not
P  104. shown). The finding of an increased BMI associated with
a decreased lean body mass suggests that diabetic pa-
tients presented with an increase in fat mass. Consis-
tently, in the present series, obesity was found in 13% of104), albumin (P  103), and prealbumin (P  102)
diabetics and only 5% of non-diabetics. During diabetesremained independent predictors of survival. In diabetic
mellitus, associated gastrointestinal dysfunction such aspatients, among all the parameters tested by univariate
gastroparesis, as well as abnormal insulin action mayanalysis, only age (P  104) significantly influenced
contribute to alter protein status. It is of interest to notesurvival. Figure 3 and Table 6 show Kaplan-Meier plots
that such an alteration of protein status was observed inof survival in diabetics and non-diabetics according to
the absence of well-recognized causes of undernutritionquartiles of serum albumin and prealbumin. In non-dia-
such as inadequate dialysis [28], acidosis, and insufficientbetics, but not in diabetics, the lowest quartiles of albu-
protein intake. Pre-dialysis plasma bicarbonate and pro-min and prealbumin significantly influenced survival.
tein intake as estimated by nPCR were not different in
both groups. Weekly dialysis duration was similar in
DISCUSSION diabetic and non-diabetic patients. Kt/V values were
As previously reported in French hemodialysis pa- above the recommended target [19], attesting the ade-
tients during the last decade [20], diabetics represented quacy of dialysis dose in most of diabetic as in non-
about 11% of the studied population. Such a prevalence diabetic patients. Kt/V was slightly lower in diabetics
of diabetes mellitus in our 1996 series is slightly smaller (by 5%). However, the reduction in albumin, prealbumin
than recently reported in European dialysis centers and lean body mass values observed in diabetic patients
[21–24] and much smaller than reported in a U.S. series persisted when we considered only patients with Kt/V
[25]. As in other nutritional studies in dialysis patients, 1.2, suggesting that the lower Kt/V did not account for
data from type 1 and type 2 diabetic patients were ana- the alteration of protein status observed during diabetes.
lyzed together [7–10]. In accordance with recent French A limitation of the present study is the fact that, as in
studies, diabetes type 1 represented approximately 10% other large cooperative studies [11, 29], urine collection
of diabetic hemodialysis patients [21]. It must be noted was not performed. As dialysis vintage was shorter
that, due to the poor tolerance and potential hazard of among diabetics, residual renal function might have been
oral hypoglycemic drugs, most of the patients with type greater in these patients as compared to non-diabetics.
2 diabetes received insulin. The decrease in vintage ob- As a consequence, in diabetic patients, the lack of urine
served in the present series traduces the poor prognosis collection might have led to an underestimation of nPCR
of diabetic patients. As a matter of fact, in dialysis centers and lean body mass as calculated from urea and creati-
involved in these studies, transplantation rates were simi- nine kinetics. Similarly, a higher urine output in patients
lar in diabetic and non-diabetic patients. The low per- with diabetic glomerulopathy might have contributed to
centage of diabetic patients treated by self-dialysis and decrease serum albumin concentrations. However, most
home-dialysis also suggests that altered general status of patients (83% of diabetics and 88% of non-diabetics)
and cardiovascular co-morbidity in this group of patients were under maintenance hemodialysis for more than one
jeopardize such self-care treatment modalities [26]. year. According to usual European data on residual renal
From a nutritional perspective, as observed in bio- function during maintenance hemodialysis [30, 31], it
seems likely that very few of these patients presentedimpedance-analysis studies [27], the main characteristic
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Fig. 3. Cumulative survival according to quar-
tile distribution of albumin and prealbumin in
diabetic (N  170) and non-diabetic patients
(N  1357). Symbols are: () quartile 1; ()
quartile 2; () quartile 3; () quartile 4. By
the Log rank (Mantel-Cox) test, significance
was: (A ) serum albumin quartiles in diabetics,
NS, and non-diabetics, 2  104.73 and P 
0.0001; (B ) serum prealbumin quartiles in dia-
betics, NS, and non-diabetics, 2  69.41 and
P  0.0001.
Table 6. Quartile limits of albumin and prealbumin values in BMI 22.9 4.4 versus 25.7 5.1 (P 0.0001) and nPCR
diabetic and non-diabetic renal patients
1.13  0.30 g/kg/day versus 1.11  0.30 g/kg/day (NS).
Albumin g/L Prealbumin mg/L Low serum albumin, reduced muscle mass and increased
fat mass reported in diabetic patients from our seriesQuartile Diabetic Non-diabetic Diabetic Non-diabetic
are in accordance with other reports in these patients1 35 36.5 253 270
2 35–39 36.5–40 253–310 270–330 [7, 27]. In diabetics, the association of decreased plasma
3 39–42 40–43 310–350 330–390 proteins and muscle mass with a protein intake similar
4 42 43 350 390
to that of non-diabetics suggests that diabetes is responsi-
ble for a decrease of the yield of protein intake, in terms
of protein synthesis. Abnormal insulin and growth factor
action on protein synthesis may account for such an
significant urine output (1 to 2% of patients with urine
alteration in protein metabolism. C-reactive protein and
output 500 mL/day). Moreover, as diabetes induces a serum amyloid A have been shown to be increased in
rapid loss of renal function during hemodialysis [32], diabetic as compared to non-diabetic hemodialysis pa-
the probability that, in the present series, residual renal tients [33]. Markers of the acute phase reaction were
function was greater in diabetics than in non-diabetics not recorded in this series, which was designed in 1995.
seems to be very low. Thus, it seems unlikely that the However, infectious diseases at the time of data collec-
lack of urine collection in our study might significantly tion (4.9 vs. 2.3%) and history of surgery within the last
modify the comparison of serum albumin, nPCR and month (5.6 vs. 2.4%) were more frequent in diabetic
lean body mass in the two groups. As a matter of fact, than in non-diabetic patients (2  77.78, P  0.0001),
when patients that had been treated with hemodialysis suggesting a higher incidence of inflammation. Thus, in
for less than one year where excluded from analysis, our series, a lowering effect of inflammation on albumin
similar results were achieved: albumin was 39.0  5.2 and prealbumin plasma levels is likely. Similarly, al-
g/L in non-diabetics versus 38.2  5.2 g/L in diabetics though complementary studies are needed concerning
(P  0.01), prealbumin 338  94 mg/L versus 316  93 the effect of uremia-induced inflammation on protein
mg/L (P  0.0001), predialysis creatinine 831  214 kinetics [34], the role of inflammation in the reduction of
mol/L versus 744  178 mol/L (P  0.0001), LBM muscle mass has been recently underscored [35]. Hence,
from the data presented here, we propose that diabeticobs/exp 0.88  0.20 versus 0.79  0.17 (P  0.0001),
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hemodialysis patients accumulate metabolic conditions our series, the death risk was not directly related to poor
protein status. The proportion of patients deceased fromthat lead to a poor protein status.
A recent review of worldwide survival studies per- cardiac failure, vascular disease, infections and malignant
diseases was similar in diabetics and non-diabetics. Suchformed from 1993 to 1998 in diabetic hemodialysis pa-
tients showed large variations according to considered a finding suggests that diabetes was associated with an
increased death risk from these causes and not only fromcountries. The mean actuarial five-year survival was 60%
in non-diabetics and 33% during type 2 diabetes [36]. In cardiac or vascular diseases, as recently mentioned in
the U.S. Renal Data System Annual Data Report, the French reports [24, 38, 39]. This observation is in accor-
one-year death rate during hemodialysis (1996 data col- dance with epidemiological series in non-uremic subjects
lection, censored at first transplant) was 23.2% in diabet- showing that hyperinsulinemia is associated with in-
ics, 13.2% during glomerulonephritis and 17.6% during creased all-cause and cardiovascular mortality indepen-
hypertensive nephropathy [37]. Present data showing a dent of other risk factors [42]. Both uremia [43] and
one-year death rate of 16.3% in diabetics and 9.7% in diabetes [44] are associated with oxidative stress. Be-
non-diabetics are in accordance with these previous stud- cause oxidative stress is involved in the pathogenesis of
ies. The poor prognosis of diabetic patients on hemodial- cardiovascular as well as non-cardiovascular diseases,
ysis is usually attributed to higher rates of cardiac and such as infections [45] and cancer [46], the cumulative
vascular disease mainly due to the associated lipid abnor- effects of renal failure and diabetes on oxidative status
malities [4, 24, 38, 39]. The aim of the longitudinal survey may contribute to the increased death risk in hemodialy-
was to evaluate the impact of diabetes as well as the sis diabetic patients.
role of dialysis and malnutrition in the outcome of these Results from the present cross-sectional series show
patients. Of interest is the fact that diabetic and non- that from a nutritional point of view, diabetic as com-
diabetic patients transplanted during the follow-up pe- pared with non-diabetic hemodialysis patients are char-
riod presented with similar dialysis and nutritional pro- acterized by an increased incidence of overweight and
files. This finding is likely a consequence of patient selec- overall by a higher frequency of protein malnutrition.
tion for kidney graft. As it is well recognized, diabetes The longitudinal survey confirms that diabetes during
mellitus is associated with a significant reduction of pa- hemodialysis is associated with an increased risk of
tient survival in hemodialysis. Although weekly dialysis death. The survival study shows that nutritional deple-
duration was lower in deceased than in still-on-dialysis tion is associated with an increase of mortality rates in
non-diabetics patients, dialysis results per se failed to non-diabetic but not in diabetic patients, and suggests
impact the survival rate of diabetic as in non-diabetic that diabetes is responsible for an increased mortality
patients. As discussed elsewhere, our data may be ex- risk whatever the cause of death.
plained by the fact that most of patients received ade-
quate dialysis [1]. Overweight, which is more frequent ACKNOWLEDGMENTS
in diabetic patients, was reported to be associated with
The authors acknowledge the participation of following dialysisa better survival in dialysis [40]. In the present series, centers (location) involved in this study: Centre Hospitalier Ge´ne´ral
overweight was not related to the outcome in either (Aix En Provence); Centre Hospitalier (Agen); Centre Hospitalier
(Ajaccio); Centre Hospitalo-Universitaire (Angers); Centre Hospi-diabetic or non-diabetic patients. It also has been sug-
talier (Annecy); Centre Hospitalier Ge´ne´ral (Annonay); Centregested that diabetes-associated malnutrition may be re- d’He´modialyse Michel Basse (Aressy); Centre d’He´modialyse de
sponsible for increased mortality risk more than diabetes Provence (Aubagne); Clinique de l’Orangerie (Aubervilliers); Clinique
d’Aulnay (Aulnay-Sous-Bois); Centre Hospitalier (Avignon); Cliniqueper se. In 17,185 hemodialysis patients, Lowrie et al re-
Delay and Centre Hospitalier Coˆte Basque (Bayonne); Centre Hospi-ported that adding creatinine, albumin, and blood urea talier (Bethune); Centre d’He´modialyse (Blois); Hoˆpital Avicenne
nitrogen concentrations to their statistical model elimi- (Bobigny); Hoˆpital de la Croix Rouge (Bois Guillaume); Polyclin-
ique Bordeaux-Nord-Aquitaine, Hoˆpital St-Andre´, Hoˆpital Pellegrin,nated diabetes as a significant predictor of death risk [41].
CTMR - St Augustin, and Centre Hospitalo-Universitaire - PellegrinIn the present series, considering the overall population, (Bordeaux); Centre Hospitalier Duchenne (Boulogne sur Mer); Centre
age, diabetes, albumin, prealbumin appeared as indepen- Hospitalier (Bourg en Bresse); Centre Hospitalier Re´gional (Brest);
Centre Hospitalier (Brianc¸on); Centre Hospitalo-Universitaire - Cle´m-dent predictors of mortality. Nutritional data collected
enceau (Caen); Centre Hospitalier (Cambrai); Centre Hospitalierat the time of inclusion showed that non-diabetic patients
(Chalon Sur Saone); Centre d’He´modialyse (Chateauroux); Centre
who deceased during the follow-up were characterized Hospitalier Pasteur (Cherbourg); Centre Hospitalier (Cholet); Po-
lyclinique St Coˆme (Compiegne); Centre Hospitalier Ge´ne´ral - Louisby reduced predialysis creatinine, albumin, prealbumin
Pasteur (Dole); Centre Hospitalier Ge´ne´ral (Dunkerque); Centre Hos-and lean body mass (Table 3). At the opposite, among
pitalier Ge´ne´ral (Flers); Centre d’He´modialyse Jeanne d’Arc (Gien);
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